Skip Navigation
The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients
Search
Home » Advanced Search
Search Results for Continuous Glucose Monitoring
Perform Another (Advanced) Search
25 Results within Entire Site
Limit results to show: Entire Site Clinical Trial Listings Newly Approved Drugs Research Center Profiles Industry Providers New Medical Results Clinical Trials Today Headlines
Displaying results 1—20
Next > Last »
1. Study Posting (799) Trial #158659, Diabetes Mellitus, Type 1, Boston, MA ...Three daytime outpatient visits at the Diabetes Research Center, including nutritional counseling, teaching of the Continuous Glucose Monitoring System(CGMS). 2. Two overnight inpatient hospital stays during which blood samples will be ...View Page
2. Study Posting (799) Trial #157616, Diabetes Mellitus, Type 1, Boston, MA ...Three daytime outpatient visits at the Diabetes Research Center, including nutritional counseling, teaching of the Continuous Glucose Monitoring System(CGMS). 2. Two overnight inpatient hospital stays during which blood samples will be ...View Page
3. CenterWatch Clinical Research Profile (5194) Trial #2118, Diablo Clinical Research, Walnut Creek, CA ...research in diabetes including islet cell regeneration and preservation, nerve regeneration for diabetic neuropathy and continuous glucose monitoring. We have a dedicated on-site staff including two RNs, a senior coordinator, research ...View Page
4. Study Posting (5335) Trial #153189, Diabetes Mellitus, Type 2, Renton, WA ...screening and throughout the duration of the trial • Use of any product containing acetaminophen during continuous glucose monitoring periods and 24 hours prior to insertion of CGM device. • Present conditions requiring the ...View Page
5. Study Posting (5335) Trial #153198, Diabetes Mellitus, Type 2, Dallas, TX ...screening and throughout the duration of the trial • Use of any product containing acetaminophen during continuous glucose monitoring periods and 24 hours prior to insertion of CGM device. • Present conditions requiring the ...View Page
6. Study Posting (5335) Trial #153188, Diabetes Mellitus, Type 2, Austin, TX ...screening and throughout the duration of the trial • Use of any product containing acetaminophen during continuous glucose monitoring periods and 24 hours prior to insertion of CGM device. • Present conditions requiring the ...View Page
7. Study Posting (5335) Trial #153199, Diabetes Mellitus, Type 2, Greenville, NC ...screening and throughout the duration of the trial • Use of any product containing acetaminophen during continuous glucose monitoring periods and 24 hours prior to insertion of CGM device. • Present conditions requiring the ...View Page
8. Study Posting (5335) Trial #153201, Diabetes Mellitus, Type 2, Greenville, NC ...screening and throughout the duration of the trial • Use of any product containing acetaminophen during continuous glucose monitoring periods and 24 hours prior to insertion of CGM device. • Present conditions requiring the ...View Page
9. Study Posting (5335) Trial #156055, Diabetes Mellitus, Type 2, Asheville, NC ...screening and throughout the duration of the trial • Use of any product containing acetaminophen during continuous glucose monitoring periods and 24 hours prior to insertion of CGM device. • Present conditions requiring the ...View Page
10. Study Posting (5335) Trial #153200, Diabetes Mellitus, Type 2, Rochester, NY ...screening and throughout the duration of the trial • Use of any product containing acetaminophen during continuous glucose monitoring periods and 24 hours prior to insertion of CGM device. • Present conditions requiring the ...View Page
11. Study Posting (5335) Trial #153197, Diabetes Mellitus, Type 2, St. Louis, MO ...screening and throughout the duration of the trial • Use of any product containing acetaminophen during continuous glucose monitoring periods and 24 hours prior to insertion of CGM device. • Present conditions requiring the ...View Page
12. Study Posting (5335) Trial #154274, Diabetes Mellitus, Type 2, Auburn, ME ...screening and throughout the duration of the trial • Use of any product containing acetaminophen during continuous glucose monitoring periods and 24 hours prior to insertion of CGM device. • Present conditions requiring the ...View Page
13. Study Posting (5335) Trial #153203, Diabetes Mellitus, Type 2, Idaho Falls, ID ...screening and throughout the duration of the trial • Use of any product containing acetaminophen during continuous glucose monitoring periods and 24 hours prior to insertion of CGM device. • Present conditions requiring the ...View Page
14. Study Posting (5335) Trial #153202, Diabetes Mellitus, Type 2, Honolulu, HI ...screening and throughout the duration of the trial • Use of any product containing acetaminophen during continuous glucose monitoring periods and 24 hours prior to insertion of CGM device. • Present conditions requiring the ...View Page
15. Study Posting (5335) Trial #153193, Diabetes Mellitus, Type 2, Atlanta, GA ...screening and throughout the duration of the trial • Use of any product containing acetaminophen during continuous glucose monitoring periods and 24 hours prior to insertion of CGM device. • Present conditions requiring the ...View Page
16. Study Posting (5335) Trial #156054, Diabetes Mellitus, Type 2, West Palm Beach, FL ...screening and throughout the duration of the trial • Use of any product containing acetaminophen during continuous glucose monitoring periods and 24 hours prior to insertion of CGM device. • Present conditions requiring the ...View Page
17. Study Posting (5335) Trial #153196, Diabetes Mellitus, Type 2, Miami, FL ...screening and throughout the duration of the trial • Use of any product containing acetaminophen during continuous glucose monitoring periods and 24 hours prior to insertion of CGM device. • Present conditions requiring the ...View Page
18. Study Posting (5335) Trial #153190, Diabetes Mellitus, Type 2, Clearwater, FL ...screening and throughout the duration of the trial • Use of any product containing acetaminophen during continuous glucose monitoring periods and 24 hours prior to insertion of CGM device. • Present conditions requiring the ...View Page
19. Study Posting (5335) Trial #153194, Diabetes Mellitus, Type 2, Auroroa, CO ...screening and throughout the duration of the trial • Use of any product containing acetaminophen during continuous glucose monitoring periods and 24 hours prior to insertion of CGM device. • Present conditions requiring the ...View Page
20. Study Posting (5335) Trial #153191, Diabetes Mellitus, Type 2, Walnut Creek, CA ...screening and throughout the duration of the trial • Use of any product containing acetaminophen during continuous glucose monitoring periods and 24 hours prior to insertion of CGM device. • Present conditions requiring the ...View Page
Copyright © 2008 Jobson Medical Information LLC.
Designed by Piehead Productions LLC.